FedCircuitBlog

• USPTO Says Interested Party Rulings Aren’t ‘Shenanigans’ – The U.S. Patent and Trademark Office defended against accusations that the agency engaged in “shenanigans” when it did not require Google to be named as an interested party during a review of a mobile website patent.
• Guitar Pedalboard Patent Sent for New PTAB Review by Fed. Cir. – The Federal Circuit ruled on Monday that the Patent Trial and Appeal Board erred when the board analyzed a guitar pedalboard patent and rejected an earlier electrical relay patent as analogous prior art.
• Heart Monitor Maker Asks High Court to Clear Eligibility Muddle – InfoBionic Inc. suggests that a Supreme Court review of its case involving a dispute over a cardiac monitoring patent could provide clarity around which inventions are eligible for patents.

Here’s the latest.

• Investors Eye Patents After ‘Extraordinary’ Damage Awards Run – The past year has seen several large damages awards in patent infringement cases but the Federal Circuit has overturned some of the larger awards.
• Federal Circuit Limits Venue for Hatch-Waxman Cases – The Federal Circuit ruled that venue was only proper in judicial districts sufficiently related to the submission of an abbreviated new drug application (“ANDA”) and not where a generic drug could be distributed.
• Fed. Circ. Mulls Fate Of Wi-Fi Co.’s $8M Infringement Verdict – Oral arguments before the Federal Circuit took place on Friday for SIMO Holdings Inc. v. Hong Kong uCloudlink Network Technology Ltd. reviewing a jury verdict of uCloudlink’s willful infringement.

Here’s the latest.

• Fed. Circ. Asked To Keep Movie Theater IP Suit In Texas – Arguing that the case should stay in Texas, Intertrust Technologies Corp. asks the Federal Circuit to reject a petition from Regal Cinemas, AMC, and Cinemark to transfer the lawsuit to California.
• Nike Golf Club Patent Dispute Do-Over Weighed by Fed. Cir. Panel – Saso Golf, Inc. urges a Federal Circuit panel to send its patent infringement case back down to the lower court and assign the case to a new a judge, even though the original suit was filed twelve years ago.
• Fed. Circ. Affirms Chevron Loss In PTAB Interference – A split Federal Circuit found that the Patent Trial and Appeal Board correctly construed a key term to find that the University of Wyoming Research Corporation was entitled to a patent involving a method for analyzing crude oil in an interference proceeding against Chevron.

Here’s the latest.

• Three Damages Questions for the Supreme Court – Cochlear Corp. petitioned the Supreme Court to review the Federal Circuit’s damages decision and recently received an amicus brief in support.
• Threshold Issues, Misdirected Lawyering, and a Frustrated Federal Circuit – Earlier this October, the Federal Circuit remanded AntennaSys, Inc., v. AQYR Technologies, Inc. to resolve the claim construction issues left undecided by the lower court and expressing their disdain towards unhelpful arguments from both parties.
• Apple Hit With $503M Verdict In VirnetX Patent Retrial – After the Federal Circuit vacated the damages award, on remand, the lower court jury awarded similar damages against Apple.

Here’s the latest.

• Wrong case, right result, Fed Circuit holds in trademark win for Sprouts Farmers Market – The Federal Circuit concluded that the TTAB correctly determined that a challenger to Corcamore, LLC’s registration for the mark SPROUTS had standing, despite the fact that the TTAB applied the incorrect legal standard.
• USPTO Sees ‘Unprecedented Growth’ In AI Patent Apps – On Tuesday, the U.S. Patent and Trademark Office published a report recognizing the surge of AI-related patent applications.
• Trademark Office Issues Guidance for Post-Booking.com World – Although the Supreme Court rejected the USPTO’s bright-line rule against generic.com, applicants still have to establish that the mark holds distinct meaning to consumers.

Here’s the latest.

• Federal Circuit to district court: Show Us Your Work on Section 101 – The Federal Circuit reversed a decision from the District of Delaware for a lack of reasoning supporting the invalidation of patent claims.
• No Pause on American Axle Case for Coming Supreme Court Petition – American Axle did not persuade the Federal Circuit to stay its case in American Axle & Manufacturing, Inc. v. Neapco Holdings LLC, but Judge Moore took the opportunity to ask for guidance from the Supreme Court on patentability.
• Determining the Likelihood that an AI Patent Application Will Be Allowed at the USPTO – The USPTO is adapting to increased interest in artificial intelligence, but decisions from the Federal Circuit and Supreme Court have caused a rise in rejections in the field.

Here’s the latest.

• Fed. Circ. Ruling Is Troubling For Generic Drug Manufacturers – In a 2-1 decision, the Federal Circuit issued an opinion addressing the role of skinny labels in an induced infringement analysis.
• Work History Tool Properly Held Ineligible for Patent Protection – The Federal Circuit issued a nonprecedential opinion on Monday affirming a district court decision that an invention directed at a method for verifying work history is too abstract to patent.
• Fed. Circ. Urged To Undo Ugg’s $450K Trademark Win – An Australian apparel company argued on Monday that the lower court used the wrong legal test in finding that “ugg” is not a generic word for a kind of sheepskin boot.

Here’s the latest.

• Full Federal Circuit Won’t Revisit Dana-Farber Win on Named Inventors – The Federal Circuit refused to rehear a case en banc involving the addition of inventors to a pharmaceutical patent.
• CAFC Affirms District Court Dismissal of Declaratory Judgment Under Doctrine of ‘Abstention’ – The Doctrine of ‘Abstention’ guided the Federal Circuit’s decision in Warsaw Orthopedic, Inc. v. Sasso to affirm the lower court’s ruling to dismiss a claim for declaratory judgment.
• Broadest Reasonable Interpretation in Light of the Specification – Snyders Heart Valve can continue its infringement claims against St. Jude’s Medical after a recent decision by the Federal Circuit.

Here’s the latest.

• Fed. Circ. Backs Sanofi, Regeneron PTAB Win Over Amgen – In a precedential opinion issued on Tuesday, the Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating Amgen’s patent aimed at treating inflammatory disorders.
• Patent Reviews in ‘Limbo’ As Supreme Court Takes Case on Judges – The U.S. Supreme Court recently announced that it will review the Federal Circuit’s decision in Arthrex Inc. v. Smith & Nephew Inc.
• Fed. Circ. Denies Appeal of Order Backing Card IP Under Alice – On Wednesday, the Federal Circuit rejected an interlocutory appeal after a district court found that a patent describing a card that can be used as a debit card, a loyalty card, and a gift card all at once was not directed to an abstract idea.

Here’s the latest.

Yesterday the Supreme Court granted the petitions for certiorari in three related Arthrex cases: (1) United States v. Arthrex, Inc. (19-1434), (2) Smith & Nephew, Inc. v. Arthrex, Inc. (19-1452), and (3) Arthrex, Inc. v. Smith & Nephew, Inc. (19-1458). The Court decided to consolidate the cases for briefing and oral argument and announced that all future filings and activity will be reflected on docket of No. 19-1434. The Court’s widely anticipated review will determine the fate of Administrative Patent Judges (APJs) under the Appointments Clause. Here are the details.